Berkshire's Class A shares gained $800, or 1.2percentto to $68,800.
Berkshire's Class B shares rose 2.8 percent, to $87.28, while its Class A shares gained 2.9 percent, to $131,300.
The Class A shares gained 4.6percentt in the 12 months through July, adjusted for the load, versus a gain of 3.2percentt for its category.
The left half of the image shows Components 3, 5 and 1, revealing a region of shared gain across all three components at 9p21 (labeled B).
Adjusting for a 3-cent-a-share gain last year on the sale of the I.B.M. Global Network and other one-time events, earnings per share increased 20percentt.
There are a number of shared gains of TEs within genic regions across asterids (Additional file 1: Table S4).
The company reported a $3 billion, or about $3.40 a share, gain on equity securities in the first quarter.
The latest quarter was buoyed by $7.2 billion, or $3.62 a share gain, from the December Mead spinoff.
The New York-based drugmaker said it earned $4.06 a share, buoyed by a $3.62 a share gain from the December Mead spinoff.
The quarter's earnings include a 3 cents a share gain and are roughly in-line with analysts' expected earnings of 23 cents a share.
In trading yesterday on the Nasdaq market, Grey Global, which rose 5.3percentt on Friday, to $895 a share, gained an additional $50, to close at a record $945.
